Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104368112 | 10436811 | 2 | F | 20160715 | 20140908 | 20160715 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-20243036 | BRISTOL MYERS SQUIBB | 0.00 | M | Y | 0.00000 | 20160715 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104368112 | 10436811 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | DOSE INCREASED TO 10 MG/DAY | U | 2E716 | 21436 | 5 | MG | TABLET | QD | ||||
| 104368112 | 10436811 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | U | 21436 | TABLET | ||||||||||
| 104368112 | 10436811 | 3 | SS | ABILIFY | ARIPIPRAZOLE | 1 | U | 21436 | TABLET | ||||||||||
| 104368112 | 10436811 | 4 | SS | ABILIFY | ARIPIPRAZOLE | 1 | U | 21436 | TABLET | ||||||||||
| 104368112 | 10436811 | 5 | SS | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | Oral | 1 TABLET IN BY MOUTH IN MORNING | U | 0 | 80 | MG | |||||||
| 104368112 | 10436811 | 6 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Oral | AS NEEDED | U | 0 | 25 | MG | TID | ||||||
| 104368112 | 10436811 | 7 | C | DEPAKOTE ER | DIVALPROEX SODIUM | 1 | Unknown | 1 TABLET IN MORNING AND 2 TABLETS AT BEDTIME | U | 0 | 500 | MG | |||||||
| 104368112 | 10436811 | 8 | C | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | 1 TABLET BY MOUTH IN MORNING | U | 0 | 250 | MG | |||||||
| 104368112 | 10436811 | 9 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 2 TABLETS BY MOUTH EVERY EVENING,50 MG 1 TABLET BY MOUTH DAILY AS NEEDED | U | 0 | 400 | MG | |||||||
| 104368112 | 10436811 | 10 | C | BENZTROPINE MESYLATE. | BENZTROPINE MESYLATE | 1 | Unknown | AS NEEDED | U | 0 | 1 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104368112 | 10436811 | 1 | Schizophrenia |
| 104368112 | 10436811 | 2 | Bipolar disorder |
| 104368112 | 10436811 | 3 | Avoidant personality disorder |
| 104368112 | 10436811 | 4 | Obsessive-compulsive disorder |
| 104368112 | 10436811 | 5 | Product used for unknown indication |
| 104368112 | 10436811 | 6 | Product used for unknown indication |
| 104368112 | 10436811 | 7 | Product used for unknown indication |
| 104368112 | 10436811 | 8 | Product used for unknown indication |
| 104368112 | 10436811 | 9 | Product used for unknown indication |
| 104368112 | 10436811 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104368112 | 10436811 | Aggression | |
| 104368112 | 10436811 | Hallucinations, mixed | |
| 104368112 | 10436811 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 104368112 | 10436811 | 1 | 201309 | 0 |